Apimeds Pharmaceuticals US, Inc. - APUS
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q3 2025
· Q2 2025
Value (USD)
Total reported value ($000)
$710K
QoQ value delta ($000)
+$221K
(+45.19%)
Implied price effect (QoQ)
+1.11%
Shares
Total shares
399,983
QoQ shares delta
+121,452
(+43.6%)
Total shares held by funds (by quarter)
Market chart (APUS)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q3 2025)
Top 25 only
Full list
Early Q4 2025 data: only 7 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Hemenway Trust Co LLC | 445 | 250,000 | 0.03% |
| VANGUARD GROUP INC | 105 | 58,992 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 54 | 30,754 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 49 | 27,893 | 0.0% |
| XTX Topco Ltd | 33 | 18,735 | 0.0% |
| HRT FINANCIAL LP | 24 | 13,572 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 8 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 29 | 0.0% |